Ameriprise’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $857K | Buy |
|
|||||
|
2025
Q2 | $111K | Buy |
|
|||||
|
2025
Q1 | $73.7K | Sell |
|
|||||
|
2024
Q4 | $370K | Buy |
|
|||||
|
2024
Q3 | $641K | Sell |
|
|||||
|
2024
Q2 | $804K | Buy |
|
|||||
|
2024
Q1 | $884K | Sell |
|
|||||
|
2023
Q4 | $9.43M | Buy |
|
|||||
|
2023
Q3 | $1.05M | Buy |
|
|||||
|
2023
Q2 | $683K | Buy |
|
|||||
|
2023
Q1 | $614K | Sell |
|
|||||
|
2022
Q4 | $14.3M | Sell |
|
|||||
|
2022
Q3 | $24.3M | Buy |
|
|||||
|
2022
Q2 | $21.4M | Sell |
|
|||||
|
2022
Q1 | $31.4M | Sell |
|
|||||
|
2021
Q4 | $51.7M | Buy |
|
|||||
|
2021
Q3 | $58.6M | Buy |
|
|||||
|
2021
Q2 | $35.2M | Buy |
|
|||||
|
2021
Q1 | $1.22M | Buy |
|
|||||
|
2020
Q4 | $312K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $150K | Sell |
|
|||||
|
2019
Q2 | $570K | Buy |
|
|||||
|
2019
Q1 | $202K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.7M | Sell |
|
|||||
|
2018
Q2 | $2.76M | Buy |
|